Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in TaxesChange in TaxesOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Change in Account Payables (2020 - 2024)

Universe Pharmaceuticals' Change in Account Payables history spans 5 years, with the latest figure at $7.8 million for Q1 2024.

  • On a quarterly basis, Change in Account Payables fell 30.92% to $7.8 million in Q1 2024 year-over-year; TTM through Mar 2024 was $7.8 million, a 30.92% decrease, with the full-year FY2025 number at -$3.1 billion, down 2279.32% from a year prior.
  • Change in Account Payables hit $7.8 million in Q1 2024 for Universe Pharmaceuticals, up from $4.6 million in the prior quarter.
  • Over the last five years, Change in Account Payables for UPC hit a ceiling of $2691.2 billion in Q3 2020 and a floor of $3.1 million in Q3 2022.
  • Historically, Change in Account Payables has averaged $384.5 billion across 5 years, with a median of $5.3 million in 2021.
  • Biggest five-year swings in Change in Account Payables: tumbled 100.0% in 2021 and later surged 208.3% in 2023.
  • Tracing UPC's Change in Account Payables over 5 years: stood at $2691.2 billion in 2020, then tumbled by 100.0% to $5.3 million in 2021, then tumbled by 42.09% to $3.1 million in 2022, then surged by 49.1% to $4.6 million in 2023, then skyrocketed by 69.32% to $7.8 million in 2024.
  • Business Quant data shows Change in Account Payables for UPC at $7.8 million in Q1 2024, $4.6 million in Q3 2023, and $11.2 million in Q1 2023.